フクダ電子（6960）のセグメントごとの売上高・利益等
セグメント通期
- 【有報】
- セグメント情報等、連結財務諸表
| 科目 | 年度 | 生体検査装置 | 生体情報モニター | 消耗品等 | 治療装置 |
|---|---|---|---|---|---|
| 売上高 | 2013/03 | 276億 | 92.6億 | 209億 | 385億 |
| 2014/03 | 347億 +25.8% | 94.6億 +2.1% | 235億 +12.7% | 399億 +3.6% | |
| 2015/03 | 327億 -5.9% | 95.3億 +0.7% | 239億 +1.7% | 422億 +5.7% | |
| 2016/03 | 367億 +12.3% | 90.1億 -5.4% | 256億 +7% | 460億 +9% | |
| 2017/03 | 369億 +0.6% | 90.9億 +0.8% | 277億 +8.5% | 481億 +4.5% | |
| 2018/03 | 393億 +6.4% | 96.6億 +6.4% | 301億 +8.5% | 499億 +3.8% | |
| 2019/03 | 389億 -0.9% | 94.8億 -2% | 313億 +4% | 501億 +0.4% | |
| 2020/03 | 382億 -1.7% | 102億 +8.1% | 343億 +9.7% | 506億 +1% | |
| 2021/03 | 404億 +5.8% | 141億 +37.4% | 370億 +7.9% | 552億 +9.1% | |
| 2022/03 | 294億 -27.3% | 129億 -8.3% | 352億 -5% | 546億 -1.1% | |
| 2023/03 | 311億 +5.6% | 116億 -10% | 365億 +3.7% | 554億 +1.6% | |
| 2024/03 | 307億 -1.3% | 97.2億 -16.4% | 402億 +10.2% | 597億 +7.7% | |
| 2025/03 | 285億 -6.9% | 97.8億 +0.6% | 387億 -3.7% | 620億 +3.8% | |
| 科目 | 年度 | 生体検査装置 | 生体情報モニター | 消耗品等 | 治療装置 |
| 営業利益 | 2013/03 | 26.6億 | 7.71億 | 18.7億 | 49.4億 |
| 2014/03 | 32.3億 +21.3% | 9.36億 +21.4% | 23億 +23.2% | 53.5億 +8.2% | |
| 2015/03 | 24.7億 -23.3% | 8.3億 -11.3% | 22.6億 -1.8% | 47.4億 -11.4% | |
| 2016/03 | 22.5億 -8.9% | 6.82億 -17.8% | 23.2億 +2.5% | 53.9億 +13.9% | |
| 2017/03 | 24.7億 +9.4% | 6.87億 +0.7% | 28.9億 +24.8% | 60.1億 +11.5% | |
| 2018/03 | 25億 +1.5% | 7.65億 +11.4% | 28.3億 -2% | 62.3億 +3.6% | |
| 2019/03 | 26.8億 +7.2% | 7.8億 +2% | 25.7億 -9.2% | 66.1億 +6.1% | |
| 2020/03 | 25.3億 -5.7% | 7.94億 +1.8% | 30.3億 +17.6% | 69.3億 +4.9% | |
| 2021/03 | 33億 +30.5% | 17.8億 +124.2% | 45.1億 +49% | 102億 +47.4% | |
| 2022/03 | 41.3億 +25.1% | 19.9億 +11.7% | 51.1億 +13.4% | 115億 +12.3% | |
| 2023/03 | 48.9億 +18.5% | 20.9億 +5.2% | 46.6億 -8.8% | 124億 +8.5% | |
| 2024/03 | 50.7億 +3.7% | 17.2億 -17.9% | 68.8億 +47.6% | 128億 +3.1% | |
| 2025/03 | 47.8億 -5.8% | 16.9億 -1.8% | 63.4億 -7.8% | 131億 +1.8% | |
| 科目 | 年度 | 生体検査装置 | 生体情報モニター | 消耗品等 | 治療装置 |
| 営業利益率 | 2013/03 | 9.6% | 8.3% | 9% | 12.8% |
| 2014/03 | 9.3% -0.3% | 9.9% +1.6% | 9.8% +0.8% | 13.4% +0.6% | |
| 2015/03 | 7.6% -1.7% | 8.7% -1.2% | 9.5% -0.3% | 11.2% -2.2% | |
| 2016/03 | 6.1% -1.5% | 7.6% -1.1% | 9.1% -0.4% | 11.7% +0.5% | |
| 2017/03 | 6.7% +0.6% | 7.6% ±0% | 10.4% +1.3% | 12.5% +0.8% | |
| 2018/03 | 6.4% -0.3% | 7.9% +0.3% | 9.4% -1% | 12.5% ±0% | |
| 2019/03 | 6.9% +0.5% | 8.2% +0.3% | 8.2% -1.2% | 13.2% +0.7% | |
| 2020/03 | 6.6% -0.3% | 7.8% -0.4% | 8.8% +0.6% | 13.7% +0.5% | |
| 2021/03 | 8.2% +1.6% | 12.6% +4.8% | 12.2% +3.4% | 18.5% +4.8% | |
| 2022/03 | 14% +5.8% | 15.4% +2.8% | 14.5% +2.3% | 21% +2.5% | |
| 2023/03 | 15.7% +1.7% | 18% +2.6% | 12.8% -1.7% | 22.5% +1.5% | |
| 2024/03 | 16.5% +0.8% | 17.7% -0.3% | 17.1% +4.3% | 21.5% -1% | |
| 2025/03 | 16.8% +0.3% | 17.2% -0.5% | 16.4% -0.7% | 21.1% -0.4% | |
| 科目 | 年度 | 生体検査装置 | 生体情報モニター | 消耗品等 | 治療装置 |
| 研究開発費 | 2013/03 | - | - | - | - |
| 2014/03 | - | - | - | - | |
| 2015/03 | - | - | - | - | |
| 2016/03 | - | - | - | - | |
| 2017/03 | - | - | - | - | |
| 2018/03 | - | - | - | - | |
| 2019/03 | 12.1億 | 3.39億 | - | 772百万 | |
| 2020/03 | 11.1億 -8.5% | 9.63億 +184.1% | 5百万 | 721百万 -6.6% | |
| 2021/03 | 14.4億 +30.1% | 13.6億 +41.2% | 1百万 -80% | 493百万 -31.6% | |
| 2022/03 | 15.5億 +7.3% | 11.5億 -15.7% | 0 | 755百万 +53.1% | |
| 2023/03 | 15.3億 -0.8% | 13.2億 +14.8% | 38百万 | 896百万 +18.7% | |
| 2024/03 | - | - | - | - | |
| 2025/03 | - | - | - | - | |
| 科目 | 年度 | 生体検査装置 | 生体情報モニター | 消耗品等 | 治療装置 |
| 固定資産増加額 | 2013/03 | 14.1億 | 472百万 | 10.6億 | 64.9億 |
| 2014/03 | 5.04億 -64.2% | 137百万 -71% | 3.41億 -67.9% | 49.3億 -24% | |
| 2015/03 | 4.28億 -15.1% | 124百万 -9.5% | 3.13億 -8.2% | 59.1億 +19.9% | |
| 2016/03 | 6.48億 +51.4% | 159百万 +28.2% | 4.51億 +44.1% | 59.3億 +0.2% | |
| 2017/03 | 6.41億 -1.1% | 156百万 -1.9% | 4.82億 +6.9% | 72.7億 +22.8% | |
| 2018/03 | 5.94億 -7.3% | 146百万 -6.4% | 4.53億 -6% | 67億 -7.9% | |
| 2019/03 | 12億 +101.2% | 291百万 +99.3% | 9.6億 +111.9% | 84.7億 +26.4% | |
| 2020/03 | 18.7億 +56.3% | 501百万 +72.2% | 16.7億 +74.2% | 95.1億 +12.3% | |
| 2021/03 | 17.4億 -6.9% | 604百万 +20.6% | 15.9億 -5.1% | 93.3億 -1.9% | |
| 2022/03 | 14.9億 -14.1% | 655百万 +8.4% | 17.9億 +12.6% | 104億 +11% | |
| 2023/03 | 11.1億 -25.4% | 417百万 -36.3% | 13.1億 -26.7% | 83億 -19.9% | |
| 2024/03 | 12.1億 +9% | 384百万 -7.9% | 15.9億 +21.6% | 117億 +41% | |
| 2025/03 | 8.87億 -26.9% | 304百万 -20.8% | 12億 -24.5% | 122億 +3.8% | |
| 科目 | 年度 | 生体検査装置 | 生体情報モニター | 消耗品等 | 治療装置 |
| 資産 | 2013/03 | 153億 | 59.6億 | 120億 | 283億 |
| 2014/03 | 194億 +27.2% | 61.7億 +3.5% | 143億 +19.2% | 311億 +9.8% | |
| 2015/03 | 184億 -5.2% | 64.5億 +4.5% | 139億 -2.2% | 323億 +4% | |
| 2016/03 | 198億 +7.4% | 62.8億 -2.7% | 143億 +2.5% | 345億 +6.9% | |
| 2017/03 | 210億 +6.1% | 68.3億 +8.8% | 159億 +11.4% | 381億 +10.4% | |
| 2018/03 | 218億 +3.8% | 67.7億 -0.8% | 169億 +5.9% | 386億 +1.3% | |
| 2019/03 | 213億 -2.4% | 65.4億 -3.5% | 179億 +6% | 394億 +2% | |
| 2020/03 | 218億 +2.4% | 69.8億 +6.7% | 204億 +14.3% | 409億 +3.9% | |
| 2021/03 | 252億 +15.7% | 95.2億 +36.4% | 225億 +10.2% | 458億 +11.9% | |
| 2022/03 | 199億 -21.3% | 99.4億 +4.5% | 241億 +7% | 481億 +5.1% | |
| 2023/03 | 217億 +9.4% | 87.4億 -12.1% | 257億 +6.6% | 507億 +5.4% | |
| 2024/03 | 211億 -3% | 75.5億 -13.6% | 273億 +6.1% | 560億 +10.4% | |
| 2025/03 | 198億 -5.9% | 74.6億 -1.2% | 261億 -4.4% | 591億 +5.6% | |
| 科目 | 年度 | 生体検査装置 | 生体情報モニター | 消耗品等 | 治療装置 |
| 減損損失 | 2013/03 | 0 | 0 | 0 | 0 |
| 2014/03 | 1百万 | 0 | 0 | 1百万 | |
| 2015/03 | 4百万 +300% | 1百万 | 3百万 | 745百万 +999.99% | |
| 2016/03 | 1百万 -75% | 0 | 1百万 -66.7% | 2百万 -99.7% | |
| 2017/03 | 133百万 +999.99% | 72百万 | 62百万 +999.99% | 83百万 +999.99% | |
| 2018/03 | 15百万 -88.7% | 3百万 -95.8% | 11百万 -82.3% | 19百万 -77.1% | |
| 2019/03 | 4百万 -73.3% | 1百万 -66.7% | 3百万 -72.7% | 5百万 -73.7% | |
| 2020/03 | 3百万 -25% | 1百万 ±0% | 3百万 ±0% | 5百万 ±0% | |
| 2021/03 | 11百万 +266.7% | 3百万 +200% | 10百万 +233.3% | 15百万 +200% | |
| 2022/03 | 82百万 +645.5% | 1百万 -66.7% | 25百万 +150% | 15百万 ±0% | |
| 2023/03 | 49百万 -40.2% | 0 | 15百万 -40% | 1百万 -93.3% | |
| 2024/03 | 59百万 +20.4% | 0 | 12百万 -20% | 0 | |
| 2025/03 | 8百万 -86.4% | - | 3百万 -75% | 3百万 | |
| 科目 | 年度 | 生体検査装置 | 生体情報モニター | 消耗品等 | 治療装置 |
| 持分法適用会社への投資額 | 2013/03 | - | - | - | 681百万 |
| 2014/03 | - | - | - | - | |
| 2015/03 | - | - | - | - | |
| 2016/03 | - | - | - | - | |
| 2017/03 | - | - | - | - | |
| 2018/03 | - | - | - | - | |
| 2019/03 | - | - | - | - | |
| 2020/03 | - | - | - | - | |
| 2021/03 | - | - | - | - | |
| 2022/03 | - | - | - | - | |
| 2023/03 | - | - | - | - | |
| 2024/03 | - | - | - | - | |
| 2025/03 | - | - | - | - | |
| 科目 | 年度 | 生体検査装置 | 生体情報モニター | 消耗品等 | 治療装置 |
| のれん | 2013/03 | - | - | - | - |
| 2014/03 | - | - | - | 831百万 | |
| 2015/03 | - | - | - | - | |
| 2016/03 | - | - | - | - | |
| 2017/03 | - | - | - | - | |
| 2018/03 | - | - | - | - | |
| 2019/03 | - | - | - | - | |
| 2020/03 | - | - | - | - | |
| 2021/03 | - | - | - | - | |
| 2022/03 | - | - | - | - | |
| 2023/03 | - | - | - | - | |
| 2024/03 | - | - | - | - | |
| 2025/03 | - | - | - | - | |
| 科目 | 年度 | 生体検査装置 | 生体情報モニター | 消耗品等 | 治療装置 |
| のれん償却額 | 2013/03 | - | - | - | - |
| 2014/03 | - | - | - | 45百万 | |
| 2015/03 | - | - | - | 175百万 +288.9% | |
| 2016/03 | - | - | - | - | |
| 2017/03 | - | - | - | - | |
| 2018/03 | - | - | - | - | |
| 2019/03 | - | - | - | - | |
| 2020/03 | - | - | - | - | |
| 2021/03 | - | - | - | - | |
| 2022/03 | - | - | - | - | |
| 2023/03 | - | - | - | - | |
| 2024/03 | - | - | - | - | |
| 2025/03 | - | - | - | - |
セグメント四半期
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
|---|---|---|---|---|---|---|
| 生体検査装置 | ||||||
| 売上高 1Q2Q 3Q | 2014/03 | 57.4億 | 77.5億 | 64.6億 | 148億 | 347億 |
| 2015/03 | 46.1億 -19.7% | 75.8億 -2.2% | 63.1億 -2.2% | 142億 -4.1% | 327億 -5.9% | |
| 2016/03 | 60.5億 +31.2% | 93.2億 +23.1% | 84.3億 +33.5% | 129億 -9.1% | 367億 +12.3% | |
| 2017/03 | 61.9億 +2.3% | 85.7億 -8% | 70.6億 -16.2% | 151億 +16.9% | 369億 +0.6% | |
| 2018/03 | 64.6億 +4.4% | 100億 +16.7% | 73.5億 +4.2% | 154億 +2.5% | 393億 +6.4% | |
| 2019/03 | 66.4億 +2.8% | 90.4億 -9.7% | 86億 +16.9% | 146億 -5.2% | 389億 -0.9% | |
| 2020/03 | 68.9億 +3.8% | 122億 +35.4% | 66億 -23.2% | 125億 -14.6% | 382億 -1.7% | |
| 2021/03 | 62.6億 -9.2% | 94.7億 -22.6% | 110億 +66.7% | 137億 +9.6% | 404億 +5.8% | |
| 2022/03 | 50.1億 -19.9% | 72.6億 -23.4% | 65.8億 -40.2% | 106億 -22.9% | 294億 -27.3% | |
| 2023/03 | 50.8億 +1.2% | 83.4億 +15% | 65.6億 -0.4% | 111億 +4.8% | 311億 +5.6% | |
| 2024/03 | 51.2億 +0.9% | 79.1億 -5.2% | 64.9億 -1% | 111億 +0.6% | 307億 -1.3% | |
| 営業利益 1Q2Q 3Q | 2014/03 | 5.34億 | 7.53億 | 4.84億 | 14.5億 | 32.3億 |
| 2015/03 | 2.84億 -46.8% | 7.12億 -5.4% | 3.67億 -24.2% | 11.1億 -23.6% | 24.7億 -23.3% | |
| 2016/03 | 3.02億 +6.3% | 6.08億 -14.6% | 4.06億 +10.6% | 9.38億 -15.6% | 22.5億 -8.9% | |
| 2017/03 | 3.89億 +28.8% | 6.42億 +5.6% | 4.86億 +19.7% | 9.5億 +1.3% | 24.7億 +9.4% | |
| 2018/03 | 4.32億 +11.1% | 7.16億 +11.5% | 4.61億 -5.1% | 8.95億 -5.8% | 25億 +1.5% | |
| 2019/03 | 3.99億 -7.6% | 6.6億 -7.8% | 5.03億 +9.1% | 11.2億 +25.4% | 26.8億 +7.2% | |
| 2020/03 | 3.65億 -8.5% | 9.54億 +44.5% | 2.86億 -43.1% | 9.25億 -17.6% | 25.3億 -5.7% | |
| 2021/03 | 2.55億 -30.1% | 7.86億 -17.6% | 8.37億 +192.7% | 14.2億 +53.8% | 33億 +30.5% | |
| 2022/03 | 5.97億 +134.1% | 10億 +27.6% | 9.33億 +11.5% | 16億 +12.2% | 41.3億 +25.1% | |
| 2023/03 | 5.83億 -2.3% | 14.8億 +47.2% | 9.41億 +0.9% | 18.9億 +18.5% | 48.9億 +18.5% | |
| 2024/03 | 7.54億 +29.3% | 16.3億 +10.3% | 9.62億 +2.2% | 17.3億 -8.5% | 50.7億 +3.7% | |
| 営業利益率 | 2014/03 | 9.3% | 9.7% | 7.5% | 9.8% | 9.3% |
| 2015/03 | 6.2% -3.1% | 9.4% -0.3% | 5.8% -1.7% | 7.8% -2% | 7.6% -1.7% | |
| 2016/03 | 5% -1.2% | 6.5% -2.9% | 4.8% -1% | 7.3% -0.5% | 6.1% -1.5% | |
| 2017/03 | 6.3% +1.3% | 7.5% +1% | 6.9% +2.1% | 6.3% -1% | 6.7% +0.6% | |
| 2018/03 | 6.7% +0.4% | 7.2% -0.3% | 6.3% -0.6% | 5.8% -0.5% | 6.4% -0.3% | |
| 2019/03 | 6% -0.7% | 7.3% +0.1% | 5.9% -0.4% | 7.7% +1.9% | 6.9% +0.5% | |
| 2020/03 | 5.3% -0.7% | 7.8% +0.5% | 4.3% -1.6% | 7.4% -0.3% | 6.6% -0.3% | |
| 2021/03 | 4.1% -1.2% | 8.3% +0.5% | 7.6% +3.3% | 10.4% +3% | 8.2% +1.6% | |
| 2022/03 | 11.9% +7.8% | 13.8% +5.5% | 14.2% +6.6% | 15.1% +4.7% | 14% +5.8% | |
| 2023/03 | 11.5% -0.4% | 17.7% +3.9% | 14.4% +0.2% | 17.1% +2% | 15.7% +1.7% | |
| 2024/03 | 14.7% +3.2% | 20.6% +2.9% | 14.8% +0.4% | 15.5% -1.6% | 16.5% +0.8% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 生体情報モニター | ||||||
| 売上高 1Q2Q 3Q | 2014/03 | 15.5億 | 19.4億 | 18.2億 | 41.5億 | 94.6億 |
| 2015/03 | 12.8億 -17.5% | 25.7億 +32.4% | 17.9億 -1.9% | 38.9億 -6.2% | 95.3億 +0.7% | |
| 2016/03 | 11.2億 -12.3% | 26億 +1.3% | 20.5億 +14.5% | 32.4億 -16.7% | 90.1億 -5.4% | |
| 2017/03 | 14.6億 +30.5% | 22.6億 -13.3% | 24.1億 +17.5% | 29.6億 -8.7% | 90.9億 +0.8% | |
| 2018/03 | 13.7億 -6.5% | 24.5億 +8.4% | 22.1億 -8.2% | 36.4億 +23.1% | 96.6億 +6.4% | |
| 2019/03 | 15億 +9.4% | 21.8億 -11% | 24.2億 +9.6% | 33.8億 -7.2% | 94.8億 -2% | |
| 2020/03 | 17.4億 +16.4% | 38億 +74.2% | 17.4億 -28% | 29.6億 -12.3% | 102億 +8.1% | |
| 2021/03 | 18億 +3.3% | 27.4億 -27.8% | 31.6億 +81.3% | 63.8億 +115.1% | 141億 +37.4% | |
| 2022/03 | 25.5億 +41.6% | 36.7億 +33.8% | 30.3億 -4% | 36.6億 -42.5% | 129億 -8.3% | |
| 2023/03 | 21.3億 -16.5% | 30.7億 -16.2% | 22.9億 -24.6% | 41.4億 +12.9% | 116億 -10% | |
| 2024/03 | 15.6億 -26.8% | 22億 -28.5% | 22.3億 -2.4% | 37.3億 -9.7% | 97.2億 -16.4% | |
| 営業利益 1Q2Q 3Q | 2014/03 | 1.53億 | 2.06億 | 1.66億 | 4.11億 | 9.36億 |
| 2015/03 | 0.9億 -41.2% | 2.49億 +20.9% | 0.96億 -42.2% | 3.95億 -3.9% | 8.3億 -11.3% | |
| 2016/03 | 0.76億 -15.6% | 2.12億 -14.9% | 1.53億 +59.4% | 2.41億 -39% | 6.82億 -17.8% | |
| 2017/03 | 1.15億 +51.3% | 1.6億 -24.5% | 1.73億 +13.1% | 2.39億 -0.8% | 6.87億 +0.7% | |
| 2018/03 | 1.18億 +2.6% | 2.17億 +35.6% | 1.68億 -2.9% | 2.62億 +9.6% | 7.65億 +11.4% | |
| 2019/03 | 1.22億 +3.4% | 1.88億 -13.4% | 1.52億 -9.5% | 3.18億 +21.4% | 7.8億 +2% | |
| 2020/03 | 1.34億 +9.8% | 3.19億 +69.7% | 0.98億 -35.5% | 2.43億 -23.6% | 7.94億 +1.8% | |
| 2021/03 | 1.45億 +8.2% | 3.54億 +11% | 3.86億 +293.9% | 8.95億 +268.3% | 17.8億 +124.2% | |
| 2022/03 | 3.44億 +137.2% | 6.57億 +85.6% | 4.72億 +22.3% | 5.16億 -42.3% | 19.9億 +11.7% | |
| 2023/03 | 2.82億 -18% | 5.99億 -8.8% | 3.64億 -22.9% | 8.47億 +64.1% | 20.9億 +5.2% | |
| 2024/03 | 2.57億 -8.9% | 4.8億 -19.9% | 3.76億 +3.3% | 6.05億 -28.6% | 17.2億 -17.9% | |
| 営業利益率 | 2014/03 | 9.9% | 10.6% | 9.1% | 9.9% | 9.9% |
| 2015/03 | 7% -2.9% | 9.7% -0.9% | 5.4% -3.7% | 10.2% +0.3% | 8.7% -1.2% | |
| 2016/03 | 6.8% -0.2% | 8.1% -1.6% | 7.5% +2.1% | 7.4% -2.8% | 7.6% -1.1% | |
| 2017/03 | 7.9% +1.1% | 7.1% -1% | 7.2% -0.3% | 8.1% +0.7% | 7.6% ±0% | |
| 2018/03 | 8.6% +0.7% | 8.9% +1.8% | 7.6% +0.4% | 7.2% -0.9% | 7.9% +0.3% | |
| 2019/03 | 8.1% -0.5% | 8.6% -0.3% | 6.3% -1.3% | 9.4% +2.2% | 8.2% +0.3% | |
| 2020/03 | 7.7% -0.4% | 8.4% -0.2% | 5.6% -0.7% | 8.2% -1.2% | 7.8% -0.4% | |
| 2021/03 | 8.1% +0.4% | 12.9% +4.5% | 12.2% +6.6% | 14% +5.8% | 12.6% +4.8% | |
| 2022/03 | 13.5% +5.4% | 17.9% +5% | 15.6% +3.4% | 14.1% +0.1% | 15.4% +2.8% | |
| 2023/03 | 13.2% -0.3% | 19.5% +1.6% | 15.9% +0.3% | 20.5% +6.4% | 18% +2.6% | |
| 2024/03 | 16.5% +3.3% | 21.9% +2.4% | 16.8% +0.9% | 16.2% -4.3% | 17.7% -0.3% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 消耗品等 | ||||||
| 売上高 1Q2Q 3Q | 2014/03 | 54億 | 53.4億 | 51.2億 | 76.2億 | 235億 |
| 2015/03 | 53億 -1.9% | 57.4億 +7.4% | 56.7億 +10.6% | 71.7億 -5.9% | 239億 +1.7% | |
| 2016/03 | 58.8億 +10.9% | 60.4億 +5.2% | 61.7億 +8.8% | 74.7億 +4.1% | 256億 +7% | |
| 2017/03 | 61.7億 +4.8% | 63.9億 +5.8% | 62.9億 +2% | 88.8億 +19% | 277億 +8.5% | |
| 2018/03 | 68.7億 +11.5% | 72.2億 +12.9% | 73億 +16% | 86.9億 -2.2% | 301億 +8.5% | |
| 2019/03 | 69.8億 +1.5% | 71.5億 -0.9% | 82.4億 +13% | 89.1億 +2.5% | 313億 +4% | |
| 2020/03 | 79.8億 +14.3% | 91.7億 +28.2% | 79.5億 -3.5% | 92.3億 +3.5% | 343億 +9.7% | |
| 2021/03 | 71.6億 -10.2% | 77.4億 -15.6% | 83.1億 +4.5% | 138億 +50% | 370億 +7.9% | |
| 2022/03 | 73.6億 +2.8% | 88.2億 +13.9% | 83.7億 +0.7% | 107億 -23% | 352億 -5% | |
| 2023/03 | 78.3億 +6.4% | 92.6億 +5% | 84億 +0.4% | 110億 +3.6% | 365億 +3.7% | |
| 2024/03 | 84億 +7.3% | 121億 +30.5% | 92.1億 +9.6% | 105億 -4.5% | 402億 +10.2% | |
| 営業利益 1Q2Q 3Q | 2014/03 | 5.78億 | 4.31億 | 4.1億 | 8.83億 | 23億 |
| 2015/03 | 3.84億 -33.6% | 6.29億 +45.9% | 3.39億 -17.3% | 9.09億 +2.9% | 22.6億 -1.8% | |
| 2016/03 | 4.7億 +22.4% | 5.7億 -9.4% | 5.15億 +51.9% | 7.63億 -16.1% | 23.2億 +2.5% | |
| 2017/03 | 5.28億 +12.3% | 7.05億 +23.7% | 6.43億 +24.9% | 10.2億 +33.2% | 28.9億 +24.8% | |
| 2018/03 | 6.94億 +31.4% | 7.89億 +11.9% | 4.48億 -30.3% | 9.03億 -11.1% | 28.3億 -2% | |
| 2019/03 | 5.58億 -19.6% | 5.88億 -25.5% | 5.65億 +26.1% | 8.61億 -4.7% | 25.7億 -9.2% | |
| 2020/03 | 6.45億 +15.6% | 10億 +70.7% | 4.12億 -27.1% | 9.64億 +12% | 30.3億 +17.6% | |
| 2021/03 | 5.66億 -12.2% | 9.78億 -2.6% | 9.01億 +118.7% | 20.6億 +114% | 45.1億 +49% | |
| 2022/03 | 9.31億 +64.5% | 13.2億 +34.8% | 11.6億 +28.2% | 17.1億 -17.2% | 51.1億 +13.4% | |
| 2023/03 | 8.17億 -12.2% | 12.7億 -3.6% | 8.15億 -29.4% | 17.6億 +2.9% | 46.6億 -8.8% | |
| 2024/03 | 13.5億 +65.1% | 27.5億 +116.2% | 13.1億 +60.6% | 14.7億 -16.2% | 68.8億 +47.6% | |
| 営業利益率 | 2014/03 | 10.7% | 8.1% | 8% | 11.6% | 9.8% |
| 2015/03 | 7.2% -3.5% | 11% +2.9% | 6% -2% | 12.7% +1.1% | 9.5% -0.3% | |
| 2016/03 | 8% +0.8% | 9.4% -1.6% | 8.4% +2.4% | 10.2% -2.5% | 9.1% -0.4% | |
| 2017/03 | 8.6% +0.6% | 11% +1.6% | 10.2% +1.8% | 11.4% +1.2% | 10.4% +1.3% | |
| 2018/03 | 10.1% +1.5% | 10.9% -0.1% | 6.1% -4.1% | 10.4% -1% | 9.4% -1% | |
| 2019/03 | 8% -2.1% | 8.2% -2.7% | 6.9% +0.8% | 9.7% -0.7% | 8.2% -1.2% | |
| 2020/03 | 8.1% +0.1% | 10.9% +2.7% | 5.2% -1.7% | 10.4% +0.7% | 8.8% +0.6% | |
| 2021/03 | 7.9% -0.2% | 12.6% +1.7% | 10.8% +5.6% | 14.9% +4.5% | 12.2% +3.4% | |
| 2022/03 | 12.6% +4.7% | 15% +2.4% | 13.8% +3% | 16% +1.1% | 14.5% +2.3% | |
| 2023/03 | 10.4% -2.2% | 13.7% -1.3% | 9.7% -4.1% | 15.9% -0.1% | 12.8% -1.7% | |
| 2024/03 | 16.1% +5.7% | 22.7% +9% | 14.2% +4.5% | 14% -1.9% | 17.1% +4.3% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 治療装置 | ||||||
| 売上高 1Q2Q 3Q | 2014/03 | 97億 | 98.5億 | 95.7億 | 108億 | 399億 |
| 2015/03 | 100億 +3.6% | 107億 +9.1% | 102億 +7.1% | 112億 +3.4% | 422億 +5.7% | |
| 2016/03 | 105億 +4.8% | 115億 +7% | 112億 +9.4% | 127億 +14.1% | 460億 +9% | |
| 2017/03 | 112億 +6.6% | 118億 +2.7% | 122億 +9% | 128億 +0.5% | 481億 +4.5% | |
| 2018/03 | 121億 +7.5% | 124億 +5.2% | 125億 +2.2% | 129億 +0.9% | 499億 +3.8% | |
| 2019/03 | 120億 -0.7% | 126億 +1.5% | 128億 +2.7% | 127億 -1.7% | 501億 +0.4% | |
| 2020/03 | 120億 ±-0% | 133億 +5.9% | 119億 -7.1% | 134億 +5.2% | 506億 +1% | |
| 2021/03 | 121億 +0.8% | 134億 +0.7% | 136億 +14.2% | 161億 +20.4% | 552億 +9.1% | |
| 2022/03 | 127億 +4.9% | 144億 +7% | 134億 -1.6% | 141億 -12.1% | 546億 -1.1% | |
| 2023/03 | 127億 -0.1% | 143億 -0.7% | 136億 +1.6% | 149億 +5.5% | 554億 +1.6% | |
| 2024/03 | 141億 +11.4% | 152億 +6.4% | 148億 +8.7% | 156億 +4.9% | 597億 +7.7% | |
| 営業利益 1Q2Q 3Q | 2014/03 | 12.4億 | 12.8億 | 11.3億 | 17億 | 53.5億 |
| 2015/03 | 9.02億 -27.5% | 12.8億 +0.2% | 7.83億 -30.4% | 17.7億 +4.2% | 47.4億 -11.4% | |
| 2016/03 | 9.32億 +3.3% | 13.9億 +8.4% | 12.4億 +58.9% | 18.3億 +3.3% | 53.9億 +13.9% | |
| 2017/03 | 11.7億 +25.6% | 15.8億 +13.3% | 15.3億 +23.3% | 17.3億 -5.1% | 60.1億 +11.5% | |
| 2018/03 | 13.7億 +17.3% | 16.9億 +7.2% | 13.3億 -13.5% | 18.4億 +6.2% | 62.3億 +3.6% | |
| 2019/03 | 13.2億 -3.6% | 15.9億 -5.7% | 15.5億 +16.5% | 21.4億 +16.5% | 66.1億 +6.1% | |
| 2020/03 | 14.5億 +9.5% | 22.9億 +43.5% | 12.1億 -21.9% | 19.9億 -7.3% | 69.3億 +4.9% | |
| 2021/03 | 13.7億 -5.5% | 25.2億 +10.3% | 25.7億 +112.9% | 37.6億 +89% | 102億 +47.4% | |
| 2022/03 | 23.2億 +69.5% | 32.1億 +27.1% | 29.2億 +13.8% | 30.3億 -19.5% | 115億 +12.3% | |
| 2023/03 | 23.5億 +1.2% | 36.9億 +15.1% | 28.9億 -1.2% | 35.2億 +16.4% | 124億 +8.5% | |
| 2024/03 | 27.4億 +16.6% | 40億 +8.3% | 26.9億 -6.9% | 34.1億 -3.1% | 128億 +3.1% | |
| 営業利益率 | 2014/03 | 12.8% | 13% | 11.8% | 15.7% | 13.4% |
| 2015/03 | 9% -3.8% | 11.9% -1.1% | 7.6% -4.2% | 15.8% +0.1% | 11.2% -2.2% | |
| 2016/03 | 8.8% -0.2% | 12.1% +0.2% | 11.1% +3.5% | 14.3% -1.5% | 11.7% +0.5% | |
| 2017/03 | 10.4% +1.6% | 13.4% +1.3% | 12.5% +1.4% | 13.5% -0.8% | 12.5% +0.8% | |
| 2018/03 | 11.4% +1% | 13.6% +0.2% | 10.6% -1.9% | 14.3% +0.8% | 12.5% ±0% | |
| 2019/03 | 11% -0.4% | 12.7% -0.9% | 12% +1.4% | 16.9% +2.6% | 13.2% +0.7% | |
| 2020/03 | 12.1% +1.1% | 17.2% +4.5% | 10.1% -1.9% | 14.9% -2% | 13.7% +0.5% | |
| 2021/03 | 11.3% -0.8% | 18.8% +1.6% | 18.9% +8.8% | 23.4% +8.5% | 18.5% +4.8% | |
| 2022/03 | 18.3% +7% | 22.3% +3.5% | 21.8% +2.9% | 21.4% -2% | 21% +2.5% | |
| 2023/03 | 18.6% +0.3% | 25.9% +3.6% | 21.2% -0.6% | 23.6% +2.2% | 22.5% +1.5% | |
| 2024/03 | 19.4% +0.8% | 26.3% +0.4% | 18.2% -3% | 21.8% -1.8% | 21.5% -1% | |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
